Showing results (2891-2900 of 3,662) with videos related to

Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|September 20, 2015
Final overall survival analysis of a phase II trial evaluating vinorelbine and lapatinib in women with ErbB2 overexpressing metastatic breast cancerWolfgang Janni, Tomasz Sarosiek, Boguslawa Karaszewska, et al.
Breast (Edinburgh, Scotland)|September 22, 2015
Neoadjuvant treatment of breast cancer--Clinical and research perspectiveSibylle Loibl, Carsten Denkert, Gunter von Minckwitz
Breast (Edinburgh, Scotland)|August 10, 2015
Optimal adjuvant treatment for patients with HER2-positive breast cancer in 2015Dimitrios Zardavas, Tamer M Fouad, Martine Piccart
Breast (Edinburgh, Scotland)|August 11, 2015
Impact of preventive therapy on the risk of breast cancer among women with benign breast diseaseJack Cuzick, Ivana Sestak, Mangesh A Thorat
Breast (Edinburgh, Scotland)|October 4, 2015
Breast conservative surgery and local recurrenceMahdi Rezai, Stefan Kraemer, Rainer Kimmig, et al.
Breast (Edinburgh, Scotland)|October 5, 2015
Radiologists' interpretive efficiency and variability in true- and false-positive detection when screen-reading with tomosynthesis (3D-mammography) relative to standard mammography in population screeningTony M Svahn, Petra Macaskill, Nehmat Houssami
Breast (Edinburgh, Scotland)|November 19, 2015
Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancerEriko Tokunaga, Nami Yamashita, Hiroyuki Kitao, et al.
Breast (Edinburgh, Scotland)|November 21, 2015
Psychiatric morbidity and non-participation in breast cancer screeningLine Flytkjær Jensen, Anette Fischer Pedersen, Bodil Hammer Bech, et al.
Breast (Edinburgh, Scotland)|January 24, 2016
Information requirements of young women with breast cancer treated with mastectomy or breast conserving surgery: A systematic reviewAlejandra Recio-Saucedo, Sue Gerty, Claire Foster, et al.
Breast (Edinburgh, Scotland)|January 24, 2016
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumabOnder Tonyali, Ugur Coskun, Sinemis Yuksel, et al.
Pageof 367